Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Irving

Showing results (311-320 of 321) with videos related to

Pageof 33
Sort By:
Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Nature Communications|September 16, 2016
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis CKhaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, et al.
Nature Communications|March 6, 2015
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseMohammed Eslam, Ahmed M Hashem, Reynold Leung, et al.
The Journal of General Virology|June 16, 2021
Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United KingdomJoseph G Chappell, Theocharis Tsoleridis, Gemma Clark, et al.
Journal of Hepatology|November 24, 2015
FibroGENE: A gene-based model for staging liver fibrosisMohammed Eslam, Ahmed M Hashem, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|January 30, 2016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypesMohammed Eslam, Alessandra Mangia, Thomas Berg, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Scientific Reports|February 7, 2019
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanismsRasha El Sharkawy, Ali Bayoumi, Mayada Metwally, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Transfusion|October 3, 2024
International review of blood donation screening for anti-HBc and occult hepatitis B virus infectionMichael X Fu, Helen M Faddy, Daniel Candotti, et al.
Pageof 33

Showing results (311-320 of 321) with videos related to

Sort By:
Pageof 33
Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Nature Communications|September 16, 2016
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis CKhaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, et al.
Nature Communications|March 6, 2015
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseMohammed Eslam, Ahmed M Hashem, Reynold Leung, et al.
The Journal of General Virology|June 16, 2021
Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United KingdomJoseph G Chappell, Theocharis Tsoleridis, Gemma Clark, et al.
Journal of Hepatology|November 24, 2015
FibroGENE: A gene-based model for staging liver fibrosisMohammed Eslam, Ahmed M Hashem, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|January 30, 2016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypesMohammed Eslam, Alessandra Mangia, Thomas Berg, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Scientific Reports|February 7, 2019
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanismsRasha El Sharkawy, Ali Bayoumi, Mayada Metwally, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Transfusion|October 3, 2024
International review of blood donation screening for anti-HBc and occult hepatitis B virus infectionMichael X Fu, Helen M Faddy, Daniel Candotti, et al.
Pageof 33